Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Gough

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Rheumatology (Oxford, England)|April 21, 2011
Use of conservative and surgical foot care in an inception cohort of patients with rheumatoid arthritisMichael R Backhouse, Anne-Maree Keenan, Elizabeth M A Hensor, et al.
Rheumatology Advances in Practice|August 22, 2019
Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective studyGavin Clunie, Iain B McInnes, Nick Barkham, et al.
Arthritis Research & Therapy|July 31, 2015
Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigationSarah Louise Mackie, John C Taylor, Lubna Haroon-Rashid, et al.
Lancet (London, England)|March 6, 2004
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialLars Klareskog, Désirée van der Heijde, Julien P de Jager, et al.
Arthritis and Rheumatism|September 30, 2008
Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritisVictoria Bejarano, Mark Quinn, Philip G Conaghan, et al.
American Journal of Human Genetics|March 31, 2015
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibilityF David Carmona, Sarah L Mackie, Jose-Ezequiel Martín, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Rheumatology (Oxford, England)|April 21, 2011
Use of conservative and surgical foot care in an inception cohort of patients with rheumatoid arthritisMichael R Backhouse, Anne-Maree Keenan, Elizabeth M A Hensor, et al.
Rheumatology Advances in Practice|August 22, 2019
Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective studyGavin Clunie, Iain B McInnes, Nick Barkham, et al.
Arthritis Research & Therapy|July 31, 2015
Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigationSarah Louise Mackie, John C Taylor, Lubna Haroon-Rashid, et al.
Lancet (London, England)|March 6, 2004
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialLars Klareskog, Désirée van der Heijde, Julien P de Jager, et al.
Arthritis and Rheumatism|September 30, 2008
Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritisVictoria Bejarano, Mark Quinn, Philip G Conaghan, et al.
American Journal of Human Genetics|March 31, 2015
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibilityF David Carmona, Sarah L Mackie, Jose-Ezequiel Martín, et al.
Pageof 4